
CartiHeal (Israel) Announces FDA IDE Approval of its Agili-C Implant for the Treatment of Joint Surface Lesions
Israeli company CartiHeal (2009), developer of a cell-free, off-the-shelf implant for use…

Israeli company CartiHeal (2009), developer of a cell-free, off-the-shelf implant for use…

A new class of biological pacemaker is promising notable advantages over traditional,…

The Medical Corps of the Israel Defense Forces (IDF) has collaborated with…

Millions of disabled people and seniors worldwide suffering from impaired walking, are…

A new Tel Aviv University study identified a gene coding for a protein that…